These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2559331)

  • 1. Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.
    Schömig E; Michael-Hepp J; Schönfeld CL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):495-501. PubMed ID: 2559331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
    Kress HG; Schömig E
    Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
    Schömig E; Michael-Hepp J; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
    Bönisch H; Harder R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transport of (+)-amphetamine by the neuronal noradrenaline carrier.
    Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):267-72. PubMed ID: 6514010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.
    Schömig E; Körber M; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):626-32. PubMed ID: 2851105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts.
    Kurz T; Offner B; Schreieck J; Richardt G; Tölg R; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):491-6. PubMed ID: 8751077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of extracellular pH reductions on [(3)H]D-aspartate and [(3)H]noradrenaline release by presynaptic nerve terminals isolated from rat cerebral cortex.
    D'Amico M; Samengo I; Martire M
    J Neural Transm (Vienna); 2010 Jan; 117(1):27-34. PubMed ID: 19779800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).
    Schömig E; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):412-7. PubMed ID: 3029604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.
    Michael-Hepp J; Blum B; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):203-7. PubMed ID: 1333059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylisopropylamiloride diminishes changes in intracellular Na, Ca and pH in ischemic newborn myocardium.
    Liu H; Cala PM; Anderson SE
    J Mol Cell Cardiol; 1997 Aug; 29(8):2077-86. PubMed ID: 9281440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term inhibition of the Na-H exchanger limits acidosis and reduces ischemic injury in the rat heart.
    Schaefer S; Ramasamy R
    Cardiovasc Res; 1997 May; 34(2):329-36. PubMed ID: 9205547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraneuronal uptake of noradrenaline in rabbit dental pulp: evidence of identity with uptake1.
    Marino V; de la Lande IS; Parker DA; Dally J; Wing S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):166-72. PubMed ID: 1448181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuronal transport mechanism for noradrenaline is not influenced by the ATP analogue ATP gamma S.
    Gliese M; Babin-Ebell J; Schömig E; Russ H
    Life Sci; 1994; 55(15):PL267-70. PubMed ID: 7934610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells).
    Schömig E; Schönfeld CL
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):404-10. PubMed ID: 2164161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use-dependent block of atrial sodium current by ethylisopropylamiloride.
    Gold MR; Strichartz GR
    J Cardiovasc Pharmacol; 1991 May; 17(5):792-9. PubMed ID: 1713995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline.
    Raisman R; Sette M; Pimoule C; Briley M; Langer SZ
    Eur J Pharmacol; 1982 Mar; 78(3):345-51. PubMed ID: 7067730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of (+/-)-dobutamine on adrenergic nerve endings.
    Fischer P; Burger A; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):79-84. PubMed ID: 2786150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.